Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-26

Clinical Trial Update: A Study of Pertuzumab in Combination With Herceptin in Patients With HER2 Positive Breast Cancer. [Phase 2]

View source ↗

Summary

This document reports the results of a Phase 2 clinical trial evaluating pertuzumab in combination with trastuzumab (Herceptin) in patients with HER2-positive b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HERCEPTIN (trastuzumab)
  • Perjeta (pertuzumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-01-26